ONCOLYTIC IMMUNOTHERAPY Trademark

Serial Number: 98452032

ONCOLYTIC IMMUNOTHERAPY is a trademark filed by CG Oncology, Inc. on March 15, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

CG Oncology, Inc. (7 trademarks)

400 Spectrum Center Dr., Suite 2040
Irvine, CA 92618

Entity Type: 03

Legal Representation

Attorney of Record

Perry J. Viscounty

4,919 trademarks filed View all →

Correspondence Address

Perry J. Viscounty Latham & Watkins LLP

650 Town Center Drive, 20th Floor

LATHAM & WATKINS LLP

Costa Mesa, CA 92626

United States

Trademark Details

Filing Date

March 15, 2024

Registration Date

Not Registered

First Use Anywhere

July 1, 2023

First Use in Commerce

July 1, 2023

Goods & Services

Pharmaceutical products for the treatment of cancer; pharmaceutical preparations and biological preparations for the treatment of cancer and immunological disorders; Biopharmaceuticals for the treatment of cancer, namely, antibodies, non-antibody proteins, blood and blood components, stem cells, hormones, blood factors, tumor necrosis factors; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune diseases; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing

Pharmaceutical research and development; Providing medical and scientific research information in the fields of oncology, autoimmune disorders, immunotherapy, immunotherapeutics, biotechnology, biopharmaceuticals, pharmaceuticals, therapies, diseases, and disorders